DeLisser H M, Newman P J, Albelda S M
Dept of Medicine, University of Pennsylvania Medical Center, Philadelphia 19104.
Immunol Today. 1994 Oct;15(10):490-5. doi: 10.1016/0167-5699(94)90195-3.
Among vascular cell adhesion molecules, platelet-endothelial cell adhesion molecule (PECAM-1/CD31) has the distinctive feature of being expressed on several of the major cell types associated with the vascular compartment. This makes it uniquely positioned to mediate multiple and important cell-cell interactions involving platelets, leukocytes and endothelial cells. Thus, PECAM-1 may represent a potential target for new therapeutic agents directed at a variety of pathological states.
在血管细胞黏附分子中,血小板内皮细胞黏附分子(PECAM-1/CD31)具有独特的特征,即在与血管腔相关的几种主要细胞类型上表达。这使其处于独特的位置,能够介导涉及血小板、白细胞和内皮细胞的多种重要细胞间相互作用。因此,PECAM-1可能代表针对多种病理状态的新型治疗药物的潜在靶点。